HERON THERAPEUTICS, INC. /DE/ (HRTX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, HERON THERAPEUTICS, INC. /DE/ reported revenue of $154.90M, up 7.4% from the prior year. The company ran a net loss, with a net margin of -13.0% and a gross margin of 73.3%. It held $255.88M in total assets against $241.54M in total liabilities.
Key ratios (FY2025)
73.3%
Gross margin
-1.6%
Operating margin
-13.0%
Net margin
-140.9%
Return on equity
+7.4%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $154.90M | $144.28M | $127.04M | $107.67M | $86.35M | $88.64M | $145.97M | $77.47M | $30.77M | $1.28M |
| Cost of Revenue | $41.35M | $38.65M | $65.11M | $54.87M | $46.02M | $36.19M | $61.62M | $27.51M | $4.59M | $35.0K |
| Gross Profit | $113.56M | $105.64M | $61.94M | $52.80M | — | — | — | — | — | — |
| Operating Income | -$2.54M | -$11.53M | -$110.61M | -$174.66M | -$217.83M | -$228.16M | -$210.69M | -$183.94M | -$194.56M | -$170.91M |
| Net Income | -$20.20M | -$13.58M | -$110.56M | -$182.02M | -$220.68M | -$227.28M | -$204.75M | -$178.84M | -$197.48M | -$173.14M |
| EPS (Diluted) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | — | — | — | — | — |
| Total Assets | $255.88M | $233.15M | $222.51M | $250.95M | $305.71M | $353.56M | $512.78M | $462.18M | $234.31M | $67.48M |
| Total Liabilities | $241.54M | $266.80M | $256.48M | $237.38M | $228.14M | $117.06M | $108.95M | $92.02M | $103.17M | $88.73M |
| Shareholders' Equity | $14.33M | -$33.65M | -$33.97M | $13.57M | $77.57M | $236.49M | $403.83M | $370.16M | $131.14M | -$21.25M |
| Cash & Equivalents | $28.65M | $25.80M | $28.68M | $15.36M | $90.54M | $105.14M | $71.90M | $31.84M | $144.58M | $13.41M |
| Operating Cash Flow | -$27.59M | -$22.53M | -$58.79M | -$146.91M | -$203.35M | -$184.82M | -$124.58M | -$191.81M | -$170.30M | -$134.10M |
| Capital Expenditures | $317.0K | $1.71M | $1.54M | $1.82M | $3.02M | $6.81M | $7.15M | $9.17M | $2.55M | $3.13M |
| Shares Outstanding | 188.31M | 152.13M | 150.29M | 119.15M | 102.00M | 91.31M | 90.30M | 78.17M | 64.61M | 39.4K |